| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |